Beta Bionics, Inc.
BBNX
$28.31
-$1.07-3.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 67.01% | 97.91% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 67.01% | 97.91% | -- | -- | -- |
| Cost of Revenue | 69.47% | 101.37% | -- | -- | -- |
| Gross Profit | 65.00% | 95.05% | -- | -- | -- |
| SG&A Expenses | 71.45% | 85.32% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.88% | 80.64% | -- | -- | -- |
| Operating Income | -69.03% | -62.89% | -- | -- | -- |
| Income Before Tax | -40.27% | -34.77% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -40.27% | -34.77% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40.27% | -34.77% | -- | -- | -- |
| EBIT | -69.03% | -62.89% | -- | -- | -- |
| EBITDA | -71.01% | -64.83% | -- | -- | -- |
| EPS Basic | 51.64% | 40.72% | -- | -- | -- |
| Normalized Basic EPS | 51.65% | 40.72% | -- | -- | -- |
| EPS Diluted | 51.64% | 40.72% | -- | -- | -- |
| Normalized Diluted EPS | 51.65% | 40.72% | -- | -- | -- |
| Average Basic Shares Outstanding | 401.32% | 276.58% | -- | -- | -- |
| Average Diluted Shares Outstanding | 401.32% | 276.58% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |